FDBusiness.com

Chr. Hansen still sees probiotic potential despite ‘insufficient’ trial data

 Breaking News
  • UK Supermarkets are Struggling to Grow The latest grocery market share figures, published by Kantar, show year-on-year supermarket sales were flat during the 12 weeks to 11 August 2019 as the tough comparisons with 2018’s strong summer continue. The memory of last year still looms large for retailers and this summer’s comparatively poor weather, combined with low levels of like-for-like price [...]...
  • Tickets Still Available For 2019 Irish Food & Drink Business Awards Some tickets are still available for the 2019 Irish Food & Drink Business Awards presentation ceremony and gala dinner to be held at the Citywest Hotel in Dublin on the evening of Thursday, 5 September 2019. The winners of the 2019 Awards will be named at the event. The prestigious awards programme, which was first introduced [...]...
  • Nestlé UK Launches New On-trend Flavours Nestlé has introduced two new on-trend flavours to its much-loved Munchies brand in the UK and Ireland. Available in 101g sharing bags, new Munchies Chocolate Fudge Brownie and Munchies Cookie Dough are the first new Munchies products since 1996. The new flavours were created at Nestlé’s confectionery sites in York and Fawdon, Newcastle. Munchies Brand Manager [...]...
  • Dedicated Industry Forums Take on Packaging’s Hottest Topics Experts from major brands, such as Coca-Cola, Ella’s Kitchen and REN Clean Skincare, will take to the stage as part of the dedicated industry forums for the beauty, food and drink sectors at Packaging Innovations and Luxury Packaging London 2019. The show, which returns to Olympia on 11 & 12 September, will tackle the key subjects [...]...
  • Greene King Being Sold For £2.7 Billion CK Asset, which is one of the largest property developers in Hong Kong and an international investment group, has made a recommended £2.7 billion cash offer for Greene King, the UK’s leading integrated brewer and pub retailer operating over 2,700 pubs, restaurants and hotels across England, Wales and Scotland. Including debt, the enterprise value of [...]...

Chr. Hansen still sees probiotic potential despite ‘insufficient’ trial data

April 20
13:04 2013

Chr. Hansen is still positive about probiotics – including in Europe – despite disappointing results in another two clinical trials, according to Chr. Hansen’s chief financial officer (CFO) Klaus Pedersen.

Reporting its 2013 second quarter results, the company filed impairment charges of €8m related to its two latest probiotic-related clinical trials investigating their potential gastrointestinal benefits.

“Despite indications of positive results the studies’ primary end points were not met and consequently the data is assessed to be insufficient for approval of an EU health claim,” Chr. Hansen said in a statement.

The company’s chief financial officer (CFO) Klaus Pedersen said in an interview: “No doubt we had hoped for a positive outcome…But you could say we had a little warning in the autumn,” he said, referring to similarly disappointing results from a trial investigating probiotics’ role in immunity, which also led the company to write off €4m last year.

“We do see positive effects from taking probiotics,” Pedersen said. “But we need to adjust these to what we need to provide to get an EFSA approval.”

He said that it would take a few more months to dig into the results from these latest trials, for which preliminary analysis was carried out in March. So far, no probiotic ingredients from any company have been successful in attaining a health claim under the EU’s nutrition and health claims regulation (NHCR).

The company said that probiotic sales in South America and APMEA (Asia Pacific, Middle East and Africa) had more than compensated for declining probiotic sales in Europe and North America.

“One thing is obviously the regulatory regime, which is different from region to region but there is an understanding of probiotics [globally],” Pedersen said.

As a whole, he added that the company did not see Europe as a declining market, despite declining probiotic sales and overall slow growth. The region still accounts for by far the largest proportion of C hr. Hansen’s sales.

“We will have a strong focus on cultures, including probiotics, in Europe,” Pedersen said.

He added that there is major global interest in natural colours, apart from carmine.

The company reported profit of €20.7m during the quarter, down 33% compared to the prior year period, mainly due to the impairment charges related to its clinical trials. Revenue was up 5.8% compared to Q2 last year, to €174.4m.

About Author

colin

colin

Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 11, 2019Packaging Innovations & Luxury Packaging London 2019
  • October 1, 2019PPMA Total Show
  • October 17, 2019Future Food-Tech
  • November 18, 2019Plastics Caps and Closures Conference 2019
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements